Attached files
Exhibit 32
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,
United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002
(subsections (a) and (b) of section 1350, chapter 63 of title 18,
United States Code), each of the undersigned officers of MabVax
Therapeutics Holdings, Inc., does hereby certify, to such
officer’s knowledge, that:
The Quarterly Report on Form 10-Q of MabVax Therapeutics Holdings,
Inc. for the three and nine months ended September 30, 2017, fully
complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, and the information contained in
the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of MabVax
Therapeutics Holdings, Inc.
|
|
|
|
Date:
November 7, 2017
|
|
By:
|
/s/ J. David
Hansen
|
|
|
|
J.
David Hansen
|
|
|
|
Chief
Executive Officer (Principal
Executive
Officer)
|
|
|
|
|
Date:
November 7, 2017
|
|
By:
|
/s/ Gregory P.
Hanson
|
|
|
|
Gregory
P. Hanson
|
|
|
|
Chief
Financial Officer (Principal
Financial
and Accounting Officer)
|
A signed original of this written statement required by Section 906
has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or
its staff upon request.